Device Medical Device

Igt Devices Systems Undivided

Payments companies reported to CMS as associated with Igt Devices Systems Undivided. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$88Kassociated payments (2023-2025)
227clinicians with associated payments
1company reporting

By year

2025 $88K

Payments reported as associated with Igt Devices Systems Undivided, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Cardiovascular Disease $30K
Clinical Cardiac Electrophysiology $23K
Emergency Medicine $7,801
Internal Medicine $7,609
Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,140
Vascular Surgery $4,510

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Igt Devices Systems Undivided

These are the largest totals companies reported as associated with Igt Devices Systems Undivided. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Christopher Healy Indianapolis, IN Cardiovascular Disease $11,800.04
John Andriulli Camden, NJ Cardiovascular Disease $8,421.21
Christopher Reynolds Pikeville, KY Emergency Medicine $7,801.00
Rogerio Carrillo Hialeah, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,000.00
Robert Lewis Birmingham, AL Internal Medicine $6,516.65
Rohit Mehta Charlotte, NC Cardiovascular Disease $6,171.81
Mark Metzl Evanston, IL Clinical Cardiac Electrophysiology $5,875.96
Vladimir Rankovic Atlantis, FL Clinical Cardiac Electrophysiology $5,640.00
Oliver Monfredi Charlottesville, VA Clinical Cardiac Electrophysiology $4,742.55
Erich Kiehl Newport News, VA Clinical Cardiac Electrophysiology $3,300.00

Prescribed Igt Devices Systems Undivided?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.